Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: dyslipidemia
Total 0 results
Nothing found
Sponsors and Collaborators
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Societa Italiana di Endoscopia Digestiva
Caritas Freetown
AMTC & Associates
University Medical Center Goettingen
Rui-hua Xu, MD, PhD
Alberta Children's Hospital, Calgary, Canada
Diego Hernan Giunta, MD
The Fifth Affiliated Hospital of Zunyi Medical College
Victor Montori
Cardresearch
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Donders Institute for Brain, Cognition and Behavior
Celtaxsys Aus Pty Limited
Fondren Orthopedic Group L.L.P.
Norsk Proteinintolerance, Norway
CRMBM-CEMEREM
Elim Pediatric Pharmaceuticals Inc.
San MediTech(Huzhou)Co.,Ltd.
ProteoSys AG
View Full List
Medical Conditions
Spermatogenesis Arrest
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Non-dystrophic Myotonias
Fibromyalgia Syndrome, Primary
Tularaemia
Disturbance of Activity and Attention
Atrial Fibrillation, Postoperative
Non-compressible Torso Hemorrhage
Orbital Tumor
Malignant Ascites Due to Epithelial Carcinoma
Tube Disorders Eustachian
Normal Diameter of Optic Nerve
Plasmodium Falciparum Malaria (Drug Resistant)
Prostate Cancer Recurrent
Stereotactic Radioablation for Ventricular Tachycardia
Fever, Sweats, and Hot Flashes
Postcomatose Unawareness State
Lymphedema of Arm
Auditory Hallucination, Verbal
Gynecologic Cancer
View Full List
Drug Interventions
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Ruxolitinib
Enzalutamide, Abiraterone
Flibanserin 100 mg dose every evening
Bortezomib/dexamethasone
SERETIDE Diskus
Topotecan
Indoximod
Atezolizumab
Cetrorelix 78 mg + 78 mg
Insulin
Epimedium Prenylflavonoids Extract
Lamivudine
Cytarabine ARA-C
Oxycodone, fentanyl
PF-00868554
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Polyethylene glycol 3350
Methotrexate
Mupirocin Calcium
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in Djibouti
Contract Research Organizations in El Salvador
Contract Research Organizations in Guatemala
Contract Research Organizations in Kuwait
Contract Research Organizations in Moldova
Contract Research Organizations in Nigeria
Contract Research Organizations in Rwanda
Contract Research Organizations in Serbia
Contract Research Organizations in Suriname
Contract Research Organizations in Thailand
Contract Research Organizations in Türkiye
Contract Research Organizations in Ukraine
CRO list by country
CROs in Japan
Alcami
Biotoxtech CRO
Fountain Medical Development (FMD)
Asklep
KRI, Inc. (Kansai Research Institute)
PPD
Proswell Medical Company
Medpace
Syneos Health
Bio Reliance Corporation
All CROs in Japan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe